Related Experiment Video
Updated: Apr 22, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Effectiveness of insulin solution: a comparison between different times for maintaining the solution
Carmen Maria Lazzari1, Taína Volkart2
1Programa de Pós-Graduação em Ciências Cardiológicas, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil.
Replacing insulin solutions every 24 hours is feasible for critically ill patients, showing similar blood glucose control and fewer hypoglycemia events compared to 6-hour replacements. Further studies are needed for longer infusion durations.
Area of Science:
- Critical Care Medicine
- Endocrinology
- Clinical Pharmacy
Background:
- Hyperglycemia is common in critically ill patients and linked to poor outcomes.
- Intensive blood glucose control with intravenous insulin is increasingly used.
- Evidence on the long-term efficacy and safety of insulin solutions is limited.
Purpose of the Study:
- To compare blood glucose levels between two insulin infusion protocols with different solution replacement times (6 vs. 24 hours) in critically ill patients.
- To assess the rate of hypoglycemia associated with each protocol.
- To evaluate the feasibility of 24-hour insulin solution replacement.
Main Methods:
- Retrospective chart review of 80 critically ill patients receiving insulin therapy for over 24 hours.
- Patients were divided into two groups: 40 with insulin solution replaced every 6 hours and 40 with replacement every 24 hours.
- Comparison of capillary blood glucose levels and incidence of hypoglycemia between the groups.
Main Results:
- No significant differences in blood glucose levels were observed between the 6-hour and 24-hour insulin solution replacement groups.
- Three mild hypoglycemia cases occurred in the 6-hour replacement group.
- No hypoglycemia was reported in the 24-hour replacement group.
Conclusions:
- Replacing insulin solutions every 24 hours is a feasible strategy in critically ill patients.
- The 24-hour replacement protocol demonstrated a potentially lower risk of hypoglycemia.
- Further research is needed to evaluate longer infusion times and potential hypoglycemic events.
More Related Videos
10:10Development of a Lateral Flow Immunochromatographic Strip for Rapid and Quantitative Detection of Small Molecule Compounds
Published on: November 13, 2021
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Related Concept Videos
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Drug Product Stability
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Production of Pharmaceuticals